Narrative Nonfiction
The Surgeon'sMachine
How a Pentagon prototype, a Silicon Valley startup, and a Detroit underdog reinvented surgery.
Available August 2026 · Paperback & eBook
How a Pentagon prototype, a Silicon Valley startup, and a Detroit underdog reinvented surgery.
Surgery has always been a craft of individual hands. This is the story of the machine built to change that, and the people who proved it could.
For centuries, the quality of an operation depended on the particular surgeon holding the knife. The promise of robotic surgery was to change that equation: to capture skill in a machine and make it reproducible, so the distance between the best surgeon and the average one would narrow.
The Surgeon's Machine traces how that promise was built and contested, from Cold War panic and a classified Pentagon prototype, through a Silicon Valley patent war, to a Detroit operating room where an immigrant urologist found the first real use for the machine and saved the company that made it.
It is also a business story. The robot works because the business model funds the technology, and the technology works because it changes what surgeons can do. Today more than eleven thousand of these systems operate on six continents, and the company that makes them is among the most valuable in medical history. This book explains how a breakthrough in a single operating room reshaped surgery worldwide, and where it goes next as the machine begins to learn.
How the machine changes what an operation can be, from the first robotic prostatectomy to the training that turned ninety thousand surgeons into robotic operators, and where the technology heads next.
The business behind the breakthrough: the recurring-revenue engine, the competitive moat, and the strategic question of whether the advantage is hardware or software.
A narrative history of how a transformative technology was invented and then diffused, traced from Cold War origins through the scaffolding that carried it across six continents.
Robotic surgery as a question of policy: industrial strategy, procurement and reimbursement, antitrust, and whether a technology that democratizes skill will also democratize access.
The five-century quest to industrialize the craft of surgery, from Leonardo's knight to the assembly line.
How Cold War anxiety and Pentagon research produced the first telesurgery prototype.
The rivalry, lawsuits, and merger that gave one company control of the field.
Mani Menon's audacious journey from India to leadership in American urology.
How the Henry Ford team developed the first robotic procedure, giving the machine its purpose.
The early go-to-market strategy that turned a device into a standard of care.
How Intuitive Surgical weathered crisis and fueled its own reinvention.
How robotic surgery spread across Europe and Asia, and why scaffolding decided its fate.
The pricing, training, and institutional playbook that built a market from nothing.
The challengers, platform wars, and new technologies contesting the lead.
Surgical AI, autonomy, and the questions the field has never had to answer.
The story of surgical robotics has been told in fragments — by engineers, by journalists, and even by the companies themselves — but nobody has captured the arc in full. These authors, however, bring together the saga in its entirety. From the early cardiac experiments, to the Indian adoption story that I watched unfold from Escorts to Medanta, this is the first account that connects all the pieces. It also makes clear what Raj Vattikuti, Mahendra Bhandari, and the team at the Vattikuti Foundation made possible, by chronicling a time when no one else was willing to build the ecosystem that India needed for robotic surgery to flourish.Dr. Naresh Trehan
This book deserves a wide audience, including readers well beyond the operating theatre.
Siddharth Siva worked at the Vattikuti Urology Institute at the Henry Ford Health System from 2007 to 2009, supporting clinical research on robotic prostatectomy and witnessing the evolution of robotic kidney surgery from early laboratory studies to successful human applications across multiple continents. His subsequent career in strategic finance at Fortune 10 healthcare and technology companies, including Amazon and McKesson, enables him to tell both the medical and business sides of this transformation. He has co-authored eight publications in leading medical journals. He holds degrees from Yale University (BA, Biology), Emory University (MBA), and Northwestern University (MS, Information Systems). He currently resides in the San Francisco Bay Area.
Dr. Mahendra Bhandari has been at the forefront of robotic surgery's global expansion for over two decades. As CEO of the Vattikuti Foundation since 2010, he has driven the adoption of robotic surgery across India, Europe, and the United Kingdom, training hundreds of surgeons and establishing robotic surgery programs worldwide. Working closely with Dr. Mani Menon for over four decades, he joined the Vattikuti Urology Institute at Henry Ford Health System in 2006, where he advanced robotic kidney surgery, pediatric urology, and robotic kidney transplant surgery. A distinguished figure in global urology, Dr. Bhandari pioneered cadaveric kidney transplantation in India and served as Director of Sanjay Gandhi Post Graduate Institute of Medical Sciences and Vice Chancellor of King George's Medical University. He has received the Padma Shri, one of India's highest civilian honors, and has authored over 220 publications. He is an alumnus of the University of Michigan Ross School of Business and currently resides in Miami.
Leave your name and email, and we'll send you the advance reader's sampler and keep you posted on the launch.